NAO e FANS: un’associazione pericolosa
Di Paolo Prandoni | 12 Dicembre 2019 | 0
Ultima modifica: 3 Aprile 2024
L’introduzione dei nuovi anticoagulanti diretti (NAO) nella pratica clinica ha accresciuto...
CLOT+ RSS Feed- Enhancing Pulmonary Embolism Risk Stratification: The National Early Warning Score and Its Integration into the European Society of Cardiology Classification.Thromb Haemost. 2025 Apr 8. doi: 10.1055/a-2544-3626.
- Safety and Efficacy of Factor Xa Inhibitors in Atrial Fibrillation Patients on Dialysis: Evidence from Four Randomized Controlled Trials.Thromb Haemost. 2025 Mar 24. doi: 10.1055/a-2544-7919.
- Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.N Engl J Med. 2025 Apr 10;392(14):1363-1373. doi: 10.1056/NEJMoa2416112. Epub 2025 Mar 29.